Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease

被引:4
作者
Gao, Chang [1 ]
Ding, Li [1 ]
Zhang, Xiaona [1 ]
Yuan, Menghua [1 ]
Tang, Shaofang [1 ]
Li, Wei [2 ]
Ye, Yuanyuan [1 ]
Liu, Ming [1 ]
He, Qing [1 ]
机构
[1] Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin, Peoples R China
[2] Huazhong Univ Sci & Technol, Wuhan 1 Hosp, Tongji Med Coll, Dept Endocrinol, Wuhan, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
dehydroepiandrosterone sulfate (DHEA-S); serum steroids; mass spectrometry; orthogonal partial least squares discriminant analysis (OPLS-DA); Cushing syndrome; DEHYDROEPIANDROSTERONE-SULFATE; MS/MS; ASSAY; DIAGNOSIS; DHEAS;
D O I
10.3389/fendo.2023.1158573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDifferentiating between adrenal Cushing syndrome (adrenal CS) and Cushing disease (CD) can be challenging if there are equivocal or falsely elevated adrenocorticotropic hormone (ACTH) values. We aim to investigate the diagnostic value of serum steroid profiles in differentiating adrenal CS from CD. MethodA total of 11 serum steroids in adrenal CS (n = 13) and CD (n = 15) were analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Age- and gender-specific steroid ratios were generated by dividing the actual steroid concentration by the upper limit of the relevant reference range. A principal component analysis (PCA) and an orthogonal partial least squares discriminant analysis (OPLS-DA) were performed. ResultsThe PCA and OPLS-DA analyses showed distinct serum steroid profiles between adrenal CS and CD. Dehydroepiandrosterone sulfate (DHEA-S), dehydroepiandrosterone (DHEA), and androstenedione ratios were identified as biomarkers for discrimination by variable importance in projection (VIP) in combination with t-tests. The sensitivity and specificity of DHEA-S ratios <0.40 were 92.31% (95% CI 64.0%-99.8%) and 93.33% (95% CI 68.1%-99.8%), respectively, in identifying adrenal CS. The sensitivity and specificity of DHEA ratios <0.18 were 100% (95% CI 75.3%-100.0%) and 100% (95% CI 78.2%-100.0%), respectively, in identifying adrenal CS. ConclusionOur data support the clinical use of the DHEA-S and DHEA ratios in the differential diagnosis of adrenal CS and CD, especially when falsely elevated ACTH is suspected.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Cushing's syndrome due to bilateral adrenal cortical disease: Bilateral macronodular adrenal cortical disease and bilateral micronodular adrenal cortical disease
    Araujo-Castro, Marta
    Marazuela, Monica
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [32] Cushing syndrome treated by radiofrequency ablation of adrenal gland adenoma
    Nishi, Naoko
    Tanaka, Junji
    Minagawa, Akinobu
    JAPANESE JOURNAL OF RADIOLOGY, 2012, 30 (03) : 274 - 276
  • [33] Contralateral adrenal width predicts the duration of prolonged post-surgical steroid replacement for subclinical Cushing syndrome
    Sugiura, Masahiro
    Imamura, Yusuke
    Kawamura, Koji
    Yamamoto, Satoshi
    Sazuka, Tomokazu
    Nakamura, Kazuyoshi
    Sakamoto, Shinichi
    Nagano, Hidekazu
    Koide, Hisashi
    Tanaka, Tomoaki
    Imamoto, Takashi
    Komiya, Akira
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (06) : 583 - 588
  • [34] Diurnal Salivary Cortisol Profiles in Patients with Cushing's Syndrome
    Braun, Leah T.
    Vogel, Frederick
    Zopp, Stephanie
    Rubinstein, German
    Schilbach, Katharina
    Kunzel, Heike
    Beuschlein, Felix
    Reincke, Martin
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022, 130 (07) : 434 - 438
  • [35] The effect of obesity on the outcomes of laparoscopic adrenal surgery in patients with Cushing syndrome
    Ozbebit, Orkun
    Carkit, Sedat
    Karaagac, Mustafa
    Gok, Mustafa
    Oz, Bahadir
    Dogan, Serap
    Ozturk, Figen
    Ozturk, Ahmet
    Akcan, Alper
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2024, 107 (02) : 100 - 107
  • [36] Adrenal Incidentalomas and Subclinical Cushing's Syndrome: What Are the Criteria for Surgery?
    Fassnacht, M.
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2010, 3 (04): : 16 - 20
  • [37] PPARG dysregulation as a potential molecular target in adrenal Cushing's syndrome
    Vetrivel, Sharmilee
    Tamburello, Mariangela
    Osswald, Andrea
    Zhang, Ru
    Khan, Ali
    Jung, Sara
    Baker, Jessica E.
    Rainey, William E.
    Nowak, Elisabeth
    Altieri, Barbara
    Detomas, Mario
    Watts, Deepika
    Williams, Tracy Ann
    Wielockx, Ben
    Beuschlein, Felix
    Reincke, Martin
    Sbiera, Silviu
    Riester, Anna
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [38] Fatty Liver Disease Along Cushing Syndrome Evolution
    Marengo, Maria
    Briet, Claire
    Munier, Mathilde
    Boursier, Jerome
    Rodien, Patrice
    Suteau, Valentine
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [39] Relationship between osteoporosis and Cushing syndrome based on bioinformatics
    Wang, Ding
    Dang, Chun-Xiao
    Hao, Ying-Xin
    Yu, Xiao
    Liu, Peng-Fei
    Li, Jin-Song
    MEDICINE, 2022, 101 (43)
  • [40] Cushing's disease in a patient with steroid 21-hydroxylase deficiency
    Haase, Matthias
    Schott, Matthias
    Kaminsky, Elke
    Luedecke, Dieter K.
    Saeger, Wolfgang
    Fritzen, Reimar
    Schinner, Sven
    Scherbaum, Werner A.
    Willenberg, Holger S.
    ENDOCRINE JOURNAL, 2011, 58 (08) : 699 - 706